Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDAGet Free Report) in a research note issued to investors on Friday. The brokerage set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Stock Up 7.8 %

Shares of NASDAQ:RKDA opened at $5.00 on Friday. Arcadia Biosciences has a fifty-two week low of $1.85 and a fifty-two week high of $10.31. The stock has a market cap of $6.83 million, a price-to-earnings ratio of -1.17 and a beta of 0.90. The firm’s 50 day moving average price is $4.70 and its 200 day moving average price is $3.61.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Featured Articles

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.